A New Tool to Diagnose Tuberculosis : The Xpert MTB/RIF Assay

Details

• Corporate Authors:
  National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.
• Description:
  The Xpert MTB/RIF assay is a new test that is revolutionizing tuberculosis (TB) control by contributing to the rapid diagnosis of TB disease and drug resistance. The test simultaneously detects Mycobacterium tuberculosis complex (MTBC) and resistance to rifampin (RIF) in less than 2 hours. In comparison, standard cultures can take 2 to 6 weeks for MTBC to grow and conventional drug resistance tests can add 3 more weeks. The information provided by the Xpert MTB/RIF assay aids in selecting treatment regimens and reaching infection control decisions quickly.
  
  CS245594-A
  
  Publication date from document properties.
  
  xpertmtb-rifassayfactsheet_final.pdf
  
  
• Subjects:
  Molecular Diagnostic Techniques Point-of-Care Testing Tuberculosis, Pulmonary/diagnosis Tuberculosis, Pulmonary/microbiology Tuberculosis/diagnosis Tuberculosis/ Microbiology
• Document Type:
  Pamphlet (or booklet)
• Genre:
  Fact Sheet
• Pages in Document:
  2 unnumbered pages
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha256:964eb80781663a85de111e68cfaee61b17bd150a92aaf1713b956c84ca4535c8
• Download URL:
  https://stacks.cdc.gov/view/cdc/132190/cdc_132190_DS1.pdf
• File Type:
  [PDF - 302.69 KB ]